Reading Room Production — page 155

ol D) () PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii a NIH/NIAID) [E] VIH/NIAID) [E] iy >; || (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] has asked us to ze We will be sure Please let me know if you have any questions. ) 1AM [AID DEA DART ID DIR-OCGR < NIH/NIAID) [E] )() ay P| >; Billet, From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Friday, July 12, 2024 4:06 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: URGENT ACTION by 10am Monday 7/15: Review draft NIAID TA on Risky Research Review Act Importance: High Hello all, Background Thank you very much for your quick work to comment on the Risky Research Review Act. NIH OLPA has asked us to prioritize comments to flag the most urgent or concerning items and/or those needing clarification. Action Item We have compiled the comments that meet NIH OLPA's request into the attached draft technical assistance document. Please note that NIH OLPA has requested examples, where possible. We have tried to add some examples to emphasize key points, but we welcome any suggestions and/or corrections as needed. We would appreciate your review and any edits by 10am Monday, July 15th. Given the quick turnaround, we are asking the Divisions to review concurrently with the NIAID OD. Please note that NIH OSP, NIH ORS/DOHS, and NIH OER will also be reviewing and providing comments. We will be sure to share with you any consolidated NIH comments that we receive. Thank you for your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Thursday, July 11, 2024 10:51 AM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Subject: URGENT ACTION by 12pm Friday 7/12: TA on Risky Research Review Act Importance: High Good morning, Background HHS has been asked by the Senate Homeland Security and Governmental Affairs Committee (Chair: Sen. Gary Peters, DMI; Ranking Member: Sen. Rand Paul, R-KY) to provide technical assistance (TA) on the attached draft legislation entitled the Risky Research Review Act.